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UVB radiation has been shown to induce T cell tolerance most likely via modulation of the function of antigen-
presenting cells like dendritic cells (DC), which are therefore of interest for vaccination therapy. Since little is
known about the effects of UVB-irradiated dendritic cells (UVB-DC) on CD8þ T cells, which are the dominant
effectors in various allergic and autoimmune diseases, we have investigated the potential of low dose UVB (100–
200 J per m2) irradiated bone marrow-derived dendritic cells to induce tolerance in murine CD8þ T cells speciﬁc for
the contact allergen trinitrophenyl (TNP) or for a viral peptide. In contrast to the previously reported successful
tolerization of primed CD4þ Th1 cells, neither naı¨ve CD8þ T cells nor CD8þ Tc1 effector cells or established CD8þ
T cell clones could be tolerized by TNP-modiﬁed or peptide-pulsed UVB-DC in vitro or in vivo. We observed,
however, a reduced capacity of UVB-DC to prime naı¨ve CD8þ T cells. Our data demonstrate an important difference
in the susceptibility of CD4þ and CD8þ T cells for tolerance induction using low-dose UVB-irradiated DC and have
implications for DC therapy of CD8þ T cell-mediated diseases.
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The most prominent antigen-presenting cell (APC) of the
immune system, the dendritic cell (DC), does not only
shape immune responses by skewing the differentiation of
different T cell subsets but also has the potential to induce
immune tolerance (Liu et al, 2001; Matsue et al, 2002; Moser
et al, 2003). It has been shown that low-dose UVB radiation
(UVBR) can induce antigen-specific tolerance in T lympho-
cytes in vitro or in vivo (Elmets et al, 1983; Cruz et al, 1989;
Simon et al, 1990, 1991, 1994; Denfeld et al, 2001). Thus,
DC can be transformed into a tolerogenic rather than
stimulatory APC following UVBR (Simon et al, 1990, 1991,
1994; Young et al, 1993; Denfeld et al, 2001). Furthermore, it
has been demonstrated that UVBR alters the APC function
of Langerhans cells (LC) (Weiss et al, 1995; Denfeld et al,
1998; Rattis et al, 1998). In vitro stimulation of primed CD4þ
T cells with UVB-irradiated LC was found to selectively
affect primed Th1 but not Th2 cells by the induction of
anergy in the Th1 cells. Since contact hypersensitivity (CHS)
to haptens like dinitro- (DNP) or trinitrophenyl (TNP) is
mediated by cytotoxic CD8þ Tc1 cells (Bour et al, 1995; Xu
et al, 1996; Martin et al, 2000, 2003), we have studied the
potential of low-dose UVB-irradiated bone marrow-derived
DC (UVB-DC) to induce tolerance in naı¨ve or antigen-primed
CD8þ T cells in vitro and in vivo. We tested whether UVB-
DC injected intracutaneously (i.c.) were able to induce direct
hapten-specific CD8þ T cell tolerance in TNP-specific CHS
and whether these DC could also tolerize primed TNP-
specific effector T cells in vitro. Furthermore, we used a T
cell receptor (TCR) transgenic mouse model to study the
possibility of a therapeutic application of UVB-DC for direct
tolerance induction in CD8þ naı¨ve or effector T cells
specific for conventional peptide antigens in vitro and
in vivo. We found that neither naı¨ve nor primed CD8þ T cells
could be tolerized by UVB-DC in vivo or in vitro. These
results demonstrate a fundamental difference between
CD4þ and CD8þ T cells and question the applicability of
UVB-DC for a direct tolerization of pathogenic CD8þ T cells
in vivo in allergic or autoimmune diseases.
Results
UVB-DC do not induce tolerance in TNP-induced CHS
in vivo Previous data had shown that hapten-specific
tolerance was induced with i.v. injected epidermal cell
preparations in the model of TNP-induced CHS (Cruz et al,
1989). We now used UVB irradiated bone marrow-derived
DC injected i.c. in order to test for their tolerogenic potential
in this CHS model. The time course of the experiment is
shown in Fig 1a. As shown in Fig 1b, a significant ear
swelling response was induced after sensitization of mice
with TNP-modified dendritic cells (DC-TNP) as compared to
unmodified control DC and, interestingly, also after sensi-
tization with UVB-DC-TNP, which had been irradiated with
100 J per m2 UVB. In contrast, UVB-DC-TNP, which had
been irradiated with 200 J per m2 UVB, did not sensitize for
a significant ear swelling response. In order to test whether
this suppression of the CHS response was due to the
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induction of T cell tolerance, a second CHS response was
induced in the same mice using TNCB painting (Fig 1c). We
found that in all experimental groups a prominent ear
swelling response was mounted, indicating that no toler-
ance had been induced by i.c. injection of UVB-DC-TNP in
the first CHS. Since we have previously demonstrated that
TNP-specific CHS is driven by CD8þ Tc1 effector cells
(Martin et al, 2000, 2003), we also tested for TNP-specific
cytotoxicity after the second CHS (Fig 1d). We found that in
all animal groups equally efficient TNP-specific cytotoxicity
was detectable. This clearly demonstrates the lack of T cell
tolerance induction by UVB-DC.
The viability of DC after UVB irradiation was tested by
trypan blue exclusion and microscopical inspection at
Figure 1
UVB-DC injected i.c. do not induce
hapten-specific tolerance in TNP-
mediated CHS in vivo. The experimental
protocol is shown in (a). Groups of three
mice were injected i.c. with 3  105 UVB-
DC-TNP or unirradiated DC. CHS was
elicited 5 d later by TNCB (1% in acetone)
painting on the right ear. The 24 h ear
swelling responses are shown in (b). On
day 14, mice were painted on the shaved
abdomen with 7% TNCB and CHS was
elicited by TNCB painting on the left ear 5
d later. The 24 h ear swelling response is
shown in (c). Bars give the increase in ear
thicknessþSEM. Observed differences
between experimental groups were not
statistically significant (p40.05). (d) Cyto-
toxic T cell responses of TNP-specific
effector T cells after the second CHS were
measured in a standard 4 h chromium
release assay using EL4 (2  104 per well)
cells as targets. For this purpose, 72 h
after elicitation draining auricular/maxillary
and axillary lymph node cells were resti-
mulated for 3 d in vitro and then used as
effectors in the cytotoxicity assay. Effec-
tor/target ratios were as shown. Data are
representative of three independent ex-
periments. (e) DC viability was tested by
trypan blue exclusion and counting of
viable and dead cells at the indicated time
points. Data give the number of viable
cells, which have excluded trypan blue.
One representative of three independent
experiments is shown.
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several time points (Fig 1e). We did not see a significant
decrease in DC viability, which could explain the differences
observed in T cell priming.
Naı¨ve CD8þ TNP-speciﬁc T cells cannot be tolerized by
UVB-DC in vitro To test whether UVB-DC tolerize naı¨ve
CD8þ T cells we activated T cells from spleen and lymph
nodes of C57BL/6 mice in vitro with unirradiated control or
UVB irradiated (200 J per m2) DC and tested their antigen-
specific proliferation. Similar to our CHS model, we also
found that CD8þ T cells were efficiently primed by
unirradiated DC in vitro but not by UVB-DC (Fig 2a).
CD8þ T cells from primary cultures were restimulated with
control DC in order to test whether the priming of naı¨ve
TNP-specific CD8þ T cells resulted in the induction of
tolerance. As shown in Fig 2b, T cells proliferated in a TNP
specific manner whether they had been primed with control
or UVB-irradiated DC. These data reveal the lack of
tolerance induction in naı¨ve TNP-specific CD8þ T cells by
UVB-DC in vitro.
UVB-DC fail to tolerize TNP-speciﬁc CD8þ effector T
cells Previous studies have shown that UVB-DC tolerize
established CD4þ T cell clones but not naı¨ve or primed
CD4þ T cells (Simon et al, 1994; Denfeld et al, 2001).
Therefore, we made use of an established TNP-specific
CD8þ T cell clone, T.G10, which had been derived from
lymph nodes draining a CHS site. Following stimulation with
control DC versus UVB-DC, TNP-specific proliferation was
observed in both cases (Fig 3). We conclude from these
results that in contrast to the CD4þ T cell clones AE7 or
HDK-1 (Simon et al, 1994), the hapten-specific CD8þ
effector T cells from clone T.G10 cannot be tolerized by
UVB-DC. Similar results were also seen with other TNP-
specific clones (not shown).
The low rate of thymidine incorporation is due to the fact
that established CD8þ TNP-specific T cell clones are
dependent on antigen and addition of exogenous IL-2 for
optimal proliferation. We have omitted IL-2 from the
proliferation assays to avoid that potential UVB effects
would be overcome by cytokine addition.
Reduced T cell priming capacity of UVB DC but no
tolerization of primed P14 effector T cells in vitro In
order to exclude that the lack of tolerance induction was an
unusual feature of TNP, we used conventional peptide
specific CD8þ T cells from a TCR transgenic mouse. CD8þ
P14 T cells (Pircher et al, 1989a, b) are specific for peptide
GP33 from the glycoprotein of lymphocytic choriomeningitis
virus (LCMV) in the context of H-2Db. When P14 T cells from
naı¨ve mice were primed in vitro with UVB-DC pulsed with
graded concentrations of GP33, we observed a reduction of
the proliferative response by about 100-fold as compared
to TC primed with unirradiated DC (Fig 4a) whereas the
cytotoxic effector function was comparable in both cultures
(Fig 4b). Interestingly, we found in preliminary experiments
that UVB irradiation of DC resulted in less efficient formation
of T cell blasts and a less efficient downregulation of CD62L
on days 2–4. In contrast, expression of the activation
markers CD44 and CD69 was not compromised (data
not shown). In contrast, when primed P14 T cells were
restimulated in a recall experiment with DC-GP33 we
observed no significant difference in the proliferative
capacity of P14 T cells primed with UVB-DC or P14 T cells
primed with control DC (Fig 4c). In line with our findings for
Figure 2
Naı¨ve T cells are not tolerized by
UVB-DC. Naı¨ve spleen/lymph node cells
(2  105 per well) were primed in vitro with
UVB-DC-TNP or unirradiated DC-TNP
(5  103/well). Proliferation was measured
after 5 d (a). After 7 d, T cells were
harvested and 2  104 cells per well were
restimulated with unirradiated DC-TNP
(5  103 per well). The proliferative re-
sponse was measured after 48 h (b). The
difference between the TC restimulated
with DC-TNP (black bar and open bar)
were statistically significant (p¼ 0.033).
Data are representative of three indepen-
dent experiments.
Figure3
An established TNP-specific CD8þ Tc1 clone cannot be tolerized
by UVB-DC. The TNP-specific CD8þ T cell clone T.G10 was used in a
proliferation assay with UVB-DC-TNP or unirradiated DC-TNP. Pro-
liferation was measured after 48 h. The data shown represent triplicate
measurementsþSEM. Data are representative of three independent
experiments.
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hapten-specific T cells, these results demonstrate that
also peptide specific CD8þ T cells cannot be tolerized by
UVB-DC.
Tolerance is not induced in P14 T cells by a combination
of UVB-DC and weak TCR ligands All previous results
indicated that priming of CD8þ T cells is impaired but no
tolerance can be induced by antigen pulsed UVB-DC. A
further advantage of the P14 system is the availability of the
previously characterized altered peptide ligand GP33VL,
which is a weaker ligand for the P14 TCR (Martin et al, 1996,
1998). This offers the opportunity to decrease the strength
of TCR signal in order to reveal potential tolerogenic effects
of UVB-DC. As shown in Fig 5a, b, variation of the
concentration of DC or UVB-DC used for P14 T cell priming
or the use of a fixed number of DC pulsed with graded
concentrations of GP33 or GP33VL (data not shown) did not
result in significant differences in the efficiency of T cell
priming as measured by proliferation. In fact, we also did
not observe significant differences in the secretion of IFN-g
by these T cells (data not shown). When T cells from priming
cultures with DC or UVB-DC pulsed with 108 M GP33VL
were restimulated 8 d later with DC pulsed with 108 M
GP33 or GP33VL as indicated in Fig 5c, d, we observed
comparable proliferative activities of the P14 T cells clearly
demonstrating a lack of tolerance induction upon priming
with GP33VL pulsed UVB-DC. Similar results were obtained
when DC pulsed with graded peptide concentrations were
used (data not shown).
Impaired in vivo priming capacity but lack of tolerance
induction in adoptive P14 T cell transfer We investigated
the in vivo tolerance induction using UVB-DC and adop-
tively transferred naı¨ve P14 T cells i.v. into C57BL/6
recipients (Fig 6a). The transferred T cells were primed by
subsequent i.v. injection of peptide GP33-pulsed DC and
the expansion of transgenic T cells in peripheral blood was
tested by FACS analysis on day 5 after adoptive T cell
transfer when in vivo expansion peaks. UVB-irradiation of
DC suppressed proliferation of P14 T cells to almost
background levels (Fig 6b). Surprisingly, in a recall experi-
ment performed 5 wk later with unirradiated DC, a strong
expansion of CD8þ TCR transgenic memory P14 T cells in
UVB-DC-GP33-treated mice was found. This expansion
was comparable to that of mice previously primed with
unirradiated DC-GP33 (Fig 6c). These data indicate that
despite the initial lack of significant expansion of P14 T cells
after UVB-DC-GP33 priming, CD8þ memory T cells are
efficiently generated in vivo and expand normally upon
recall.
Discussion
In our experiments using CD8þ T cells specific for the
contact sensitizer TNP or TCR transgenic CD8þ P14 T cells
specific for a conventional peptide antigen, we found that
UVBR of bone marrow-derived DC has a significant
influence on their priming capacity for naı¨ve CD8þ T cells.
In addition, primary CHS was impaired when TNP-modified
UVB-DC were injected for the sensitization of mice, but the
Figure 4
Impaired priming but no tolerance in-
duction in TCR transgenic P14 T cells
by UVB-DC. (a, b) LCMV GP33 specific
CD8þ P14 T cells (2  104 spleen and
lymph node cells per well in 96-well
plates) were primed with UVB-DC or
unirradiated DC (5  103 per well) pulsed
with the indicated concentrations of anti-
genic peptide GP33. 48 h later prolifera-
tion was measured (a) as well as
cytotoxicity using GP33-pulsed EL4 cells
(2  104 per well) as targets (b). (c) A recall
experiment was performed by restimula-
tion of the primary cultures (2  104 cells
per well) with unirradiated DC (5  103 per
well) pulsed with graded concentrations of
peptide GP33 as indicated. Proliferation
was measured after 48 h. Data represent
triplicate measurementsþSEM. Data
are representative of three independent
experiments.
948 DUDDA ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
secondary CHS response was comparable to that in mice
which had been sensitized with unirradiated DC. Similar
results have been recently reported for 2,4-dinitrofluoro-
benzene- (DNFB-) induced DTH responses using direct
UVB irradiation of mouse skin (Suzuki et al, 2003). We did
not observe tolerance induction in either naı¨ve CD8þ T cells
or established CD8þ T cell clones. In both systems used in
this study, CD8þ T cells recovered from UVB-DC priming
cultures were still capable of normal antigen-specific
proliferation upon rechallenge with unirradiated DC even
when weaker altered peptide TCR ligands had been used
for priming. Likewise, cytotoxic T cell function was not
impaired. Using another TCR transgenic mouse expressing
a TCR specific for ovalbumin on CD8þ T cells (Hogquist
et al, 1994) we obtained similar results (data not shown)
indicating a rather fundamental relevance of our findings for
CD8þ Tcells. Furthermore, the generation and expansion of
CD8þ memory T cells in the adoptive P14 transfer
Figure 6
No tolerance induction by UVB-DC
in P14 T cells in vivo. The experi-
mental protocol is shown in (a). P14
spleen cells (1.5  106 cells per
mouse) were adoptively transferred
into hosts and subsequently primed
by in vivo immunization with i.v. in-
jected UVB-DC-GP33 or unirradiated
DC-GP33 (1  106 cells per mouse).
(b) Expansion of the transgenic T cells
was measured 5 d later by analysis of
blood T cells. Five weeks later, hosts
were reimmunized with unirradiated
DC-GP33 (recall, 1  106 per mouse)
and the expansion of P14 memory T
cells measured in the blood 4 d later
(c). Observed difference between DC-
GP33 and UVB-DC-GP33-primed cells
in the recall experiment was not
statistically significant (p¼ 0.608). Data
represent the percentage of CD8þ
TCR Va2þ transgenic P14 cells in
groups of three miceþSEM.
Figure 5
No tolerance induction by UVB-DC
and altered peptide ligands in vitro.
(a, b) P14 spleen and lymph node cells
(2  104 per well) were primed in vitro
by incubation with graded numbers of
DC (closed circles) or UVB-DC (closed
triangles) pulsed with 108 M peptide
GP33 (a) or GP33VG (b), respectively.
Proliferation was measured 48 h later.
On day 8 (c, d), P14 cells from cultures
primed with 5  103 DC or UVB-DC
per well pulsed with 108 M GP33VG
were restimulated (2  104 cells per
well) with graded numbers of unirra-
diated DC pulsed with 108 M GP33 (c)
or GP33VG (d). Proliferation was mea-
sured 48 h later. Data represent the
mean of triplicate measurements 
SEM. One representative of three
independent experiments is shown.
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experiments occurred normally. Thus, although immuniza-
tion of the adoptive host with UVB-DC elicited no significant
primary proliferative response of the transgenic donor T
cells, these T cells strongly proliferated upon rechallenge to
the same extent as the control, resulting in equal blood
levels upon recall 5 wk after primary immunization. In
addition, preliminary data showed that when C57BL/6 mice
were immunized i.v. with GP33-pulsed UVB-DC or un-
irradiated DC-GP33 and subsequently infected with LCMV,
virus titers in spleen were significantly decreased after
DC-GP33 and UVB-DC-GP33 immunization compared to
control DC injection. Titers were only marginally higher
when UVB-DC-GP33 were injected. We also observed the
efficient generation of comparable GP33-specific cytotoxic
CD8þ T cell responses in both cases when T cells from
these mice were restimulated with antigen in vitro (S. Martin,
unpublished data).
It has previously been shown in vitro that the APC
function of Langerhans cells is compromised by UVBR
(Simon et al, 1991, 1994) and that the expression of
costimulatory molecules is disturbed (Young et al, 1993;
Weiss et al, 1995; Denfeld et al, 1998; Rattis et al, 1998);
however, we have recently presented data showing that the
expression of costimulatory molecules like CD80, CD86, or
CD40 on murine bone marrow-derived DC as used in this
study is not altered by UVBR (Denfeld et al, 2001).
Therefore, a lack of naı¨ve T cell costimulation via these
molecules is unlikely to be responsible for the impaired T
cell priming capacity of UVB-DC. We cannot exclude that
other molecules important for naı¨ve T cell priming are
altered in their expression or function including also soluble
factors like IL-10. We did not however observe an increased
production of IL-10 in cultures containing UVB-DC (data not
shown). Moreover, there was no evidence for a significant
increase in DC apoptosis induced during the first 24 h after
UVB irradiation, which could explain the decreased effi-
ciency of CD8þ T cell priming. A role for the Fas/FasL or
CTLA-4 has also been shown for UVB-induced tolerance
(Schwarz et al, 1998, 2000). A recent study (Wachter et al,
2003) demonstrated that UVB-DC induce CD4þ T cell
apoptosis by interference with early Tcell priming. The basis
for this effect was an impaired cytoskeletal rearrangement
important for T cell priming and a concomitant impaired
Ca2þ signaling. We cannot exclude that such processes are
responsible for the impaired CD8þ T cell priming observed
in our studies. Nevertheless, in contrast to CD4þ T cells,
CD8þ T cell apoptosis is not induced by UVB-DC. However,
our preliminary experiments indicate effects of UVB-DC on
early T cell priming events. Stimulation of naı¨ve CD8þ P14 T
cells with UVB-DC-GP33 resulted in a less efficient
formation of T cell blasts and a less efficient downregulation
of CD62L compared to priming with unirradiated DC, while
upregulation of CD69 and CD44 was unaltered (data not
shown) on days 2–4.
It is not clear to date, whether the UVB-dependent
tolerance induction observed in some systems in vivo is due
to a direct tolerization of CD4þ or CD8þ T cells or rather
depends on the induction of immunosuppressive regulatory
T cells (Sakaguchi, 2000) which prevent proliferation and
other functions of effector T cells. In fact, data from our own
laboratory indicate that such regulatory T cells can be
induced by UVB-DC (Simon et al, 2002) suggesting that the
mechanism of UVB-induced tolerance may be the active
suppression of effector T cells by induction of regulatory
T cells secreting cytokines like IL-10 or TGF-b (Sakaguchi,
2000; Simon et al, 2002).
Our data show that UVB-DC are impaired in their T cell
priming capacity but do not induce direct tolerance in
CD8þ naı¨ve or primed effector T cells. This is an important
difference to CD4þ Th1 cells, which can be efficiently
tolerized by UVB-DC (Simon et al, 1990, 1991, 1994;
Denfeld et al, 2001). Our data question the use of in vitro
generated UVB-DC for direct tolerance induction in CD8þ T
cells in vivo. It has yet to be determined however whether
UVB-DC can be used to induce a population of non-
proliferating CD8þ regulatory T cells as shown by us for
CD4þ T cells (Simon et al, 2002). In this case, it may still be
possible to use UVB-DC for tolerance induction of CD8þ T
cells via specific induction of antigen-specific regulatory T
cells. Alternatively, plasmacytoid DC or immature DC could
be used for the induction of CD8þ T cell anergy or induction
of regulatory T cells (Gilliet et al, 2002a; Kuwana et al, 2002;
Mahnke et al, 2002). In this context, it is interesting that
different types of DC can obviously be conditioned, e.g., by
CD40 triggering to induce either CD8þ T cell priming (Ridge
et al, 1998) or regulatory CD8þ T cells (Gilliet et al, 2002b). It
is tempting to speculate that DC conditioning may be
altered quantitatively or qualitatively after UVBR.
It is known that UVB irradiation of the skin can result in
the induction of T cell tolerance to contact sensitizers due to
depletion of Langerhans cells and alteration of their antigen-
presenting function (Elmets et al, 1983; Kripke, 1984;
Streilein et al, 1994; Beissert and Schwarz, 1999; Schwarz,
1999). This is most likely due to the fact that this process is
rather complex and requires, e.g., a contribution of other
cell types like mast cells (Hart et al, 1998; Alard et al, 2001).
In addition, it has been shown recently that dectin-2
expressed by Langerhans cells may play a role (Aragane
et al, 2003) and that UVB irradiation can interfere with the
expression of ICAM-1 at the elicitation site (Komura et al,
2003).
In conclusion, we have demonstrated that UVB irradiated
bone marrow-derived DC cannot be used as an easily
available therapeutic tool for direct tolerization of CD8þ
T cells.
Materials and Methods
Mice C57BL/6 mice were purchased from Charles River (Sulzfeld,
Germany) or provided by the breeding facility of the Max-Planck-
Institute for Immunobiology as were TCR transgenic P14 mice
(Pircher et al, 1989a, b). All of the experimental procedures were
carried out in accordance with the Max-Planck-Institute and the
University of Freiburg guidelines on animal welfare.
Peptides Synthetic peptides were purchased from BioChip
Technologies GmbH (Freiburg, Germany). The synthetic H-2Db
binding peptides LCMV GP33 (GP33) (Kyburz et al, 1993) and the
altered peptide ligand GP33VL (Martin et al, 1996, 1998) have been
described.
Media and chemicals RP-10 consisted of RPMI 1640 (Gibco,
Eggenstein, Germany) supplemented with 10% heat-inactivated
fetal calf serum (FCS) (Gibco), 2 mM L-glutamine (Gibco), 25 mM
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HEPES buffer (Gibco), 50 mg per mL penicillin–streptomycin
(Gibco) and 10 mM 2-mercaptoethanol (Sigma). Trinitrobenzene
sulfonic acid (TNBS) was obtained from Sigma (Deisenhofen,
Germany) and trinitrochlorobenzene (TNCB) from the Department
of Chemistry, University of Freiburg and from VeZerf Laborsynthe-
sen GmbH (Idar-Oberstein, Germany).
Generation of bone marrow-derived dendritic cells Bone
marrow was collected from the tibia and femur of 6–8-wk-old
C57BL/6 mice from the specific pathogen-free animal facility. A
single-cell suspension was prepared and erythrocytes were lysed.
After repeated washes, bone marrow cells were plated at 1  106
per well in 24-well plates in RP-10 in the presence of 40 ng per mL
GM-CSF culture supernatant and 10 ng per mL recombinant IL-4
(Promocell, Heidelberg, Germany). Cultures were fed with GM-CSF
and IL-4 at the same concentration on days 3 and 5 by replacing
half of the media. On day 6, cells were harvested and isolated over
a 14.5% metrizamide (SERVA, Heidelberg, Germany) gradient.
After repeated washes in PBS, cells were resuspendend and used
for immunization or in vitro experiments. The quality of the DC
preparation was controlled by three-color flow cytometry. Cells
were typically CD11cþ , Mac-3, GR-1, and MHC class II I-Ab
bright.
UVB irradiation DC were resuspended in PBS and irradiated with
low-dose UVB (100 or 200 J per m2) with four unfiltered FS20
fluorescent tubes (broad-band spectrum, 240–400 nm, peak at 313
nm; Westinghouse, Pittsburg, Pennsylvania) placed 46 cm above
the cells. A single dose of UVBR was given. DC viability was
determined after UVBR by plating 5  105 DC in 1 ml RP-10 in
24-well plates. Viable cells were counted based on trypan blue
exclusion at various time points.
In vitro priming of T cells with dendritic cells Cultures were set
up in 24- or 96-well plates using 5  104 or 5  103 TNP-modified
DC (DC-TNP), or peptide-pulsed DC per well, respectively, and a
mixture of 2  106 (24 well) or 2  105 (96 well) spleen/lymph node
cells from C57BL/6 or 10-fold less cells from TCR transgenic mice.
The cultures were restimulated after 7–8 d with fresh unirradiated
TNP-modified or peptide-pulsed DC.
Immunization and induction of contact hypersensitivity For
induction of contact hypersensitivity, mice were sensitized by i.c.
injection of 3  105 DC into two sites of the shaved abdomen in
2  20 mL PBS as described (Lappin et al, 1999; Martin et al, 2000,
2003) or by painting with 100 mL 7% TNCB/acetone on the shaved
abdomen. CHS was elicited by epicutaneous application of 20 mL
1% TNCB on the dorsum of one or both ears 5 d later. Ear
measurement was done prior to and 24 h after ear challenge using
an engineer’s micrometer (Mitutoyo, Leonberg, Germany). For
tolerance experiments mice were sensitized by i.c. immunization
with DC-TNP or UVB-DC-TNP followed by ear challenge on the
right ear on day 5. On day 14 after DC injection CHS was induced
by abdominal skin painting with TNCB and subsequent ear
challenge on the left ear.
In vitro T cell stimulation after CHS Auricular, maxillary, and
axillary lymph nodes were pooled and a single-cell suspension
prepared. Following lysis of erythrocytes, 4  105 cells per well
cocultured with 3  105 irradiated C57BL/6 spleen cells modified
with 3 mM TNBS for 7 min at 371C as described.13,14 On day 3,
T cells were used for cytotoxicity assays. Cultivation was carried
out in 96-well U-bottom plates (Costar, Acton, Massachusetts).
Generation of TNP-speciﬁc T cell clones Cell lines were
established by weekly restimulation of the cultures as described
above. Rat concanavalin A-induced spleen cell supernatant
(RCAS, 5 vol%) was added as a source of IL-2. After eight
restimulations TNP-specific clones were generated by plating cells
at statistically 0.3 cells per well in 96-well U-bottom plates (Costar)
adding irradiated TNP-modified spleen cellsþRCAS (5 vol%).
Positive wells were picked and the clones were expanded by
weekly restimulation. One of the TNP-specific cytotoxic CD8þ T
cell clones obtained, T.G10, was used in our studies.
Proliferation assays For primary proliferation assays, naı¨ve
spleen/lymph node cells (2  105 per well) were incubated in 96-
well plates with DC (5  104 per well) for 48 h when TCR transgenic
T cells were used or for 5 d when naı¨ve T cells from C57BL/6 mice
were used. For recall proliferation assays, T cells were harvested
from primary cultures and for some experiments depleted of
residual DC using anti-I-Ab mAb and magnetic beads (Dynal,
Hamburg, Germany) according to the manufacturer’s recommen-
dations. We did not observe significant differences with or without
depletion of residual DC. Assays were set up in 96-well plates with
2  104 T cells and 5  103 fresh DC per well and incubated for
48 h. All assays were labeled for 16 h with 1 mCi [3H]-thymidine
(Amersham, Freiburg, Germany) and harvested onto GF/C Filter
plates using Packard FilterMate (PerkinElmer, Rodgau-Jugesheim,
Germany). Plates were dried and scintillation fluid (MicroScint,
PerkinElmer) was added. Counts were measured in a b-counter
(TopCount, PerkinElmer).
Cytotoxicity assays EL4 lymphoma cells were labeled with
Na2
51CrO4 (Amersham) for 90 min, washed three times and
modified with 3 mM TNBS or left untreated. For peptide pulse,
target cells were incubated with 5 mM peptide during labeling and
washed three times. T cell cultures were harvested, washed and
threefold serial dilutions made. Target cells were added and plates
were spun for 5 min at 51 g. The assay was then incubated for 4 h
at 371C/5% CO2. Plates were spun for 5 min at 296 g and 30 mL of
supernatant transferred to Luma Plates (PerkinElmer). Counts were
measured in a TopCount (PerkinElmer) and % specific lysis
calculated using RIASmart software (PerkinElmer).
Adoptive T cell transfer and in vivo DC priming Spleen cells
from TCR transgenic P14 mice were injected i.v. into C57BL/6
hosts (1.5  106 cells per mouse) and subsequently primed by
in vivo immunization with i.v. injected UVB-DC-GP33 or unirra-
diated DC-GP33 (1  106 cells per mouse). A recall immunization
was performed 5 wk later with unirradiated DC-GP33 (1  106 cells
per mouse). Expansion of the transgenic T cell population was
measured on day 5 after the primary immunization and on day 4
after the recall immunization by flow cytometric analysis of blood
T cells. The transgenic T cells were identified by staining with anti-
CD8a (53-6.7) and TCR Va2 (B20.1) (both from BD Pharmingen,
Heidelberg, Germany).
Statistical analysis Statistical analysis was conducted using
t test. Differences were statistically significant at po0.05.
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